• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital Health | News, Analysis, Insights - HIT Consultant

Detect Depression in Seconds Wellin5 x Kintsugi Voice Biomarker Integration

by Syed Hamza Sohail 02/20/2024 Leave a Comment

Detect Depression in Seconds Wellin5 x Kintsugi Voice Biomarker Integration

What You Should Know: Wellin5, the premier provider of online counseling, proudly announces a new partnership with Kintsugi, an AI mental health technology leader.This collaboration comes at a time when Wellin5 has successfully navigated the turbulent economic landscape and challenges in the health tech space to thrive and bring this vital partnership to life, setting a new standard in mental health care for over 50,000 clients based in Canada and the USA. Revolutionizing
Read More

Unlocking Medical Device Potential: Data Integration Drives Better Patient Outcomes

by Mary Russell, MJ BS RN, Sr. Director, Clinical Services, CliniComp 02/19/2024 Leave a Comment

Unlocking Medical Device Potential: Data Integration Drives Better Patient Outcomes

The types of medical devices available and their use in patient care continue to accelerate. The medical devices market is anticipated to surpass $656B by 2032, and it is poised to reach a compound annual growth rate (CAGR) of 3.0% between 2023 and 2032. From monitoring devices, infusion pumps, implanted devices, autoinjectors and diagnostic devices to wearables, the number of devices – and the data they produce – has exploded.  For healthcare organizations, that means a constant barrage
Read More

Helmsley Trust Awards $12M to Research Exercise Management for Type 1 Diabetes

by Jasmine Pennic 02/16/2024 Leave a Comment

Helmsley Trust Awards $12M to Research Exercise Management for Type 1 Diabetes

What You Should Know: - The Leona M. and Harry B. Helmsley Charitable Trust announced a major initiative to improve the lives of people with type 1 diabetes (T1D) by awarding $12 million in grants to support research on safely incorporating exercise into their lives. - The Helmsley Charitable Trust is the world's largest private foundation dedicated to funding T1D research. With this latest initiative, the Trust has committed over $1 billion to support research efforts aimed at
Read More

CitiusTech Launches Generative AI Quality & Trust Solution

by Jasmine Pennic 02/16/2024 Leave a Comment

Bain Capital PE Makes Strategic Investment in CitiusTech

What You Should Know: - CitiusTech, a healthcare technology provider, has unveiled a groundbreaking solution to address the reliability, quality, and trust concerns surrounding Generative AI (Gen AI) in healthcare. - This industry-first offering aims to empower healthcare organizations to confidently adopt and scale Gen AI applications, unlocking their transformative potential. Gen AI Quality & Trust Solution Over 80% of Gen AI projects face delays due to lack of trust in their
Read More

Everly Health Expands Kidney Health Testing with NFK Partnership

by Syed Hamza Sohail 02/16/2024 Leave a Comment

Everly Health Expands Kidney Health Testing with NKF Partnership

What You Should Know: Everly Health, a leading remote-based healthcare company expanding access to virtual-first disease prevention, diagnosis, and treatment, today announced an educational partnership with the National Kidney Foundation aimed at informing Americans about chronic kidney disease and increasing access to screening in rural and underserved communities across the United States.Kidney disease affects 37 million adults in the United States but 90% are unaware they even have it
Read More

FDA Clears Proscia’s Digital Pathology Solution for Cancer Diagnosis

by Syed Hamza Sohail 02/16/2024 Leave a Comment

FDA Clears Proscia's AI-Powered Digital Pathology Solution for Cancer Diagnosis

What You Should Know: Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) for its Concentriq® AP-Dx*. The digital pathology solution was cleared for the purpose of primary diagnosis.Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images
Read More

FHIR Adoption on the Rise: ONC Survey Shows Digital Health Companies Embrace Standards-Based APIs

by Fred Pennic 02/15/2024 Leave a Comment

FHIR Adoption on the Rise: ONC Survey Shows Digital Health Companies Embrace Standards-Based APIs

What You Should Know: - A new survey reveals that the healthcare industry is making significant strides towards interoperability, thanks to the adoption of standards-based application programming interfaces (APIs). - The research, conducted by the Office of the National Coordinator for Health Information Technology (ONC), reveals that a majority of digital health companies are using the FHIR standard to integrate with electronic health records (EHRs). The Rise of FHIR The Cures Act
Read More

GoodRx Offers 30 Meds Under $30 for Heart Conditions

by Jasmine Pennic 02/15/2024 Leave a Comment

GoodRx Offers 30 Meds Under $30 for Heart Conditions

What You Should Know: GoodRx, a prescription savings platform, is stepping up to help with a new program offering 30 common heart health medications for under $30 at over 70,000 pharmacies nationwide. Making Heart Health Affordable - GoodRx recognizes the financial burden of managing heart disease and aims to improve access to affordable medications. By offering significant discounts on both generic and brand-name drugs, they target conditions like coronary artery disease, high
Read More

Health Systems Grapple with AI Governance: Balancing Promise and Risk

by Fred Pennic 02/15/2024 Leave a Comment

Health Systems Grapple with AI Governance: Balancing Promise and Risk

What You Should Know: - Despite the increasing adoption of artificial intelligence (AI) in healthcare, a new survey reveals that very few health systems have formal policies in place to govern its use, particularly for generative AI. In addition, 70% of executives plan to adopt AI solutions through EHR vendors for easier integration. - The Center for Connected Medicine's full report, "How Health Systems are Navigating the Complexities of AI," offers a deeper dive into the survey findings
Read More

Insilico’s Potential Best-in-Class AI Drug for Sought-After Cancer Target

by Syed Hamza Sohail 02/15/2024 Leave a Comment

Insilico's Potential Best-in-Class AI Drug for Sought-After Cancer Target

What You Should Know: InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat advanced solid tumors characterized by TP53 mutation.The development is particularly significant for high-grade serous ovarian cancer (HGSOC), triple-negative breast cancer (TNBC), and non-small cell lung cancer
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 165
  • Go to page 166
  • Go to page 167
  • Go to page 168
  • Go to page 169
  • Interim pages omitted …
  • Go to page 724
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |